Suchergebnisse - "Li, Xiaojiao"

PubPharm (14)

1

Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients : a randomized multiple-dose escalation trial

enthalten in: BMC medicine | 2023

von Jia, H. | Mai, J. | Wu, M. | +21

2

A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers

enthalten in: Expert opinion on investigational drugs | 2022

von Hu, Y. | Zhang, H. | Li, X. | +9

3

Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus : a phase 1 double-blind study in healthy subjects

enthalten in: Expert opinion on investigational drugs | 2021

von Hu, Y. | Li, H. | Wu, M. | +5

4

Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Zhang, H. | Wang, F. | Zhu, X. | +9

5

Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals

enthalten in: Expert opinion on investigational drugs | 2021

von Hu, Y. | Zhang, H. | Wu, M. | +8

6

Randomised clinical trial : safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Zhang, H. | Hu, Y. | Wu, M. | +8

7

Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine : An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects

enthalten in: Antiviral research | 2020

von Ding, Y. | Wu, M. | Zhang, H. | +7

8

Pharmacokinetics, Safety, and Tolerability of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in Healthy Chinese Subjects

enthalten in: Clinical therapeutics | 2020

von Li, C. | Li, X. | Zhu, X. | +4

9

Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection

enthalten in: Antiviral research | 2020

von Zhang, H. | Wu, M. | Zhu, X. | +9

10

Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects

enthalten in: Clinical pharmacology in drug development | 2019

von Shen, Z. | Zhu, X. | Zhang, H. | +5